Role of Growth Hormone in Breast Cancer
- 3 April 2017
- journal article
- review article
- Published by The Endocrine Society in Endocrinology
- Vol. 158 (6) , 1543-1555
Abstract
Breast cancer is one of the most common cancers diagnosed in women. Approximately two-thirds of all breast cancers diagnosed are classified as hormone dependent, which indicates that hormones are the key factors that drive the growth of these breast cancers. Ovarian and pituitary hormones play a major role in the growth and development of normal mammary glands and breast cancer. In particular, the effect of the ovarian hormone estrogen has received much attention in regard to breast cancer. Pituitary hormones prolactin and growth hormone have also been associated with breast cancer. Although the role of these pituitary hormones in breast cancers has been studied, it has not been investigated extensively. In this review, we attempt to compile basic information from most of the currently available literature to understand and demonstrate the significance of growth hormone in breast cancer. Based on the available literature, it is clear that growth hormone plays a significant role in the development, progression, and metastasis of breast cancer by influencing tumor angiogenesis, stemness, and chemoresistance.Keywords
This publication has 153 references indexed in Scilit:
- The current state of breast cancer classificationAnnals of Oncology, 2012
- Angiogenesis Induced by Signal Transducer and Activator of Transcription 5A (STAT5A) Is Dependent on Autocrine Activity of ProliferinJournal of Biological Chemistry, 2012
- Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer riskThe Lancet Oncology, 2011
- Height and prostate cancer risk: A large nested case-control study (ProtecT) and meta-analysisCancer Epidemiology, Biomarkers & Prevention, 2008
- Height, Body Mass Index, and Ovarian Cancer: A Pooled Analysis of 12 Cohort StudiesCancer Epidemiology, Biomarkers & Prevention, 2008
- The Contribution of Growth Hormone to Mammary NeoplasiaJournal of Mammary Gland Biology and Neoplasia, 2008
- The GH1/IGF-1 axis polymorphisms and their impact on breast cancer developmentBreast Cancer Research and Treatment, 2006
- The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growthBreast Cancer Research and Treatment, 2006
- Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisThe Lancet, 2004
- angiogenic activity of anterior pituitary tissue and growth hormone on the chick embryo chorio-allantoic membrane : A novel action of GHLife Sciences, 1995